RCUS
Arcus Biosciences Inc
NYSE: RCUS · HEALTHCARE · BIOTECHNOLOGY
$24.13
-2.70% today
Updated 2026-04-29
Market cap
$3.03B
P/E ratio
—
P/S ratio
12.27x
EPS (TTM)
$-3.29
Dividend yield
—
52W range
$7 – $29
Volume
1.3M
Arcus Biosciences Inc (RCUS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.94M | $-25.06M | $-43.00M | $-73.46M | $111.17M | $-256.17M | $438.00M | $-306.00M | $-170.00M | $-482.00M |
| Capital expenditures | $4.10M | $5.51M | $3.74M | $1.93M | $3.06M | $26.08M | $6.00M | $24.00M | $6.00M | $2.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $90000.00 | $495000.00 | $3.87M | $8.98M | $22.00M | $55.00M | $65.00M | $73.00M | $76.00M | $60.00M |
| Free cash flow | $-17.04M | $-30.57M | $-46.74M | $-75.39M | $108.11M | $-282.25M | $432.00M | $-330.00M | $-176.00M | $-484.00M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $5.00M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-27.36M | $-13.13M | $115.48M | $-22.70M | — | — | — | — |